Cosmetic surgery procedures done in developing countries can carry substantial risks of complications that U.S. providers and payers must handle, according to a study published in the April issue of Plastic and Reconstructive Surgery.
Kimberly M. Ross, M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues retrospectively reviewed the cases of patients who presented to the plastic surgery service of an urban tertiary academic hospital with complications or complaints associated with plastic surgery done in a developing country.
In search of a cosmetic surgery procedure that might be less costly than the going rate in the United States, a 43-year-old woman traveled to the Dominican Republic for a “tummy tuck.”
What she got, instead, were massive open sores and an antibiotic-resistant infection that ultimately left her with a deformed abdomen.
And hers is a story far from unique.
Plastic and Reconstructive Surgery‘s recently published annual supplement included data validating Sientra’s growing portfolio of implants and expanders as safe and innovative options for surgeons and patients undergoing aesthetic or reconstructive breast surgery.
The four-part supplement, which includes the Company’s finalized 10-year FDA Core Study, provides a comprehensive look at the long-term outcomes, surgical best practices and product differentiation of Sientra’s breast implants and tissue expanders.